₩ 11490
Key Takeaways
Risk factor
Poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
JW Life Science Corp. manufactures intravenous fluids. Its products include basic IV, nutrition, special fluids, irrigation agents and dialysis solutions. The company was founded on May 10, 1994 and is headquartered in Dangjin-si, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o
Data is available to registered users only